Skip to content

The effects of peripheral retinal structure and magnocellular pathway on myopia progressing in preterm children

The Effects of Peripheral Retinal Structure and Magnocellular Pathway on Myopia Progressing in Preterm Children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071487
Enrollment
Unknown
Registered
2023-05-16
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

premature infants with retinopathy of prematurity group:no
premature infants without retinopathy of prematurity group:no
full-term infants control group:no

Sponsors

the Second People’s Hospital of Foshan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: (I) gestational age was <37 weeks ; (II) the parents or guardians agreed with examinations, babies cooperated with examinations and informed consent was obtained before study; (III) subjects had no diseases of central nervous system or circulatory system (such as cerebral palsy and congenital heart disease); (IV) the refractive media had no turbidity and allowed retinoscopy; (V) there were no organic eye diseases except for ROP;

Exclusion criteria

Exclusion criteria: (I) gestational age was = 37 weeks ; (II) there was any factor causing the turbidity of refractive media, the pupils failed to be enlarged or there were other factors resulting in refractive difficulty; (III) subjects had a family history of high myopia.

Design outcomes

Primary

MeasureTime frame
spherical equivalent;axial length;lens thickness;fundus photograph;perceptual eye position;

Secondary

MeasureTime frame
height;weight;

Countries

China

Contacts

Public ContactLi Xue

the Second People’s Hospital of Foshan

leseylee@outlook.com+86 135 9289 8849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026